ICER assessing treatments for amyloidosis and prostate cancer News item 24 February 2018 Pages: 2 - 2
ICER's final report recommends pricey drug for retinal disease News item 24 February 2018 Pages: 3 - 3
Abortion ban increases costs in congenital diaphragmatic hernia Clinical study 24 February 2018 Pages: 7 - 7
Antiviral prophylaxis cost effective for perinatal hep B prevention Clinical study 24 February 2018 Pages: 8 - 8
Asprin ± clopidogrel after CABG: similar outcomes, similar cost Clinical study 24 February 2018 Pages: 9 - 9
Cu IUD for EC: most effective option, worth extra costs Clinical study 24 February 2018 Pages: 11 - 11
Dabigatran vs warfarin in NVAF: ERG risk score predicts cost Clinical study 24 February 2018 Pages: 12 - 12
Daclatasvir/asunaprevir worth its cost for chronic HCV genotype 1b Clinical study 24 February 2018 Pages: 13 - 13
Expanding aged-based HCV testing cost effective in the US Clinical study 24 February 2018 Pages: 14 - 14
Home hospital care reduces cost, maintains quality and safety Clinical study 24 February 2018 Pages: 17 - 17
Hospitalisation then intensive therapy cost effective for OCD Clinical study 24 February 2018 Pages: 19 - 19
Liraglutide add-on therapy cost effective in T2DM in Sweden Clinical study 24 February 2018 Pages: 21 - 21
Medical injections financial burden on households in Cambodia Clinical study 24 February 2018 Pages: 22 - 22
Metformin + DPP-4i cost effective for second-line treatment Clinical study 24 February 2018 Pages: 23 - 23
MRI cost-effective approach for prostate cancer detection Clinical study 24 February 2018 Pages: 24 - 24
Patient charges for prescription drugs: important implications Clinical study 24 February 2018 Pages: 25 - 25
Penicillin allergy increases hospital costs in Portugal Clinical study 24 February 2018 Pages: 26 - 26
Realistic vaccine uptake in older patients more cost effective Clinical study 24 February 2018 Pages: 27 - 27
Selective neonatal BCG vax − a cost-effective option in Ireland? Clinical study 24 February 2018 Pages: 29 - 29
Biomarin to negotiate terms with NHS for access to Brineura News item 24 February 2018 Pages: 32 - 32
New NICE guidance recommends three drugs for thyroid cancer News item 24 February 2018 Pages: 35 - 35
Niraparib may be made available for ovarian cancer on the CDF News item 24 February 2018 Pages: 36 - 36